These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 32283161)

  • 1. Duration for carrying SARS-CoV-2 in COVID-19 patients.
    Du X; Yu X; Li Q; Li X; Qin T; Luo Q; Wang M; Jiang M; Bai L; Wang X; Pan Y
    J Infect; 2020 Jul; 81(1):e78-e79. PubMed ID: 32283161
    [No Abstract]   [Full Text] [Related]  

  • 2. Duration of SARS-CoV-2 viral RNA in asymptomatic carriers.
    Yan X; Han X; Fan Y; Fang Z; Long D; Zhu Y
    Crit Care; 2020 May; 24(1):245. PubMed ID: 32448332
    [No Abstract]   [Full Text] [Related]  

  • 3. Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19).
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 35():101608. PubMed ID: 32114075
    [No Abstract]   [Full Text] [Related]  

  • 4. From SARS-CoV to SARS-CoV-2: The response and challenge of forensic infectious disease autopsy.
    Wang HJ
    Fa Yi Xue Za Zhi; 2020 Feb; 36(1):1-3. PubMed ID: 32198983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cluster of pneumonia associated with the SARS-Cov-2 outside of Wuhan related to a house-warming banquet.
    Liu L; Quan J; Lv J; Long S; Hu W; Zhuge H; Zhou Z; Zhao D
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32283138
    [No Abstract]   [Full Text] [Related]  

  • 6. Challenges and issues of SARS-CoV-2 pool testing.
    Eberhardt JN; Breuckmann NP; Eberhardt CS
    Lancet Infect Dis; 2020 Nov; 20(11):1233-1234. PubMed ID: 32679088
    [No Abstract]   [Full Text] [Related]  

  • 7. Challenges and issues of SARS-CoV-2 pool testing.
    Mishra B; Behera B; Mohanty M; Ravindra A; Ranjan J
    Lancet Infect Dis; 2020 Nov; 20(11):1233. PubMed ID: 32679083
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges and issues of SARS-CoV-2 pool testing.
    Lee J; Kim SY; Sung H; Lee SW; Lee H; Roh KH; Yoo CK; Hong KH
    Lancet Infect Dis; 2020 Nov; 20(11):1232-1233. PubMed ID: 32679080
    [No Abstract]   [Full Text] [Related]  

  • 9. Why Does SARS-CoV-2 Invade the Gastrointestinal Epithelium?
    Uno Y
    Gastroenterology; 2020 Oct; 159(4):1622-1623. PubMed ID: 32283099
    [No Abstract]   [Full Text] [Related]  

  • 10. Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19.
    Sharun K; Dhama K; Patel SK; Pathak M; Tiwari R; Singh BR; Sah R; Bonilla-Aldana DK; Rodriguez-Morales AJ; Leblebicioglu H
    Ann Clin Microbiol Antimicrob; 2020 May; 19(1):23. PubMed ID: 32473642
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV, Mers-CoV and COVID-19: what differences from a dermatological viewpoint?
    Rongioletti F
    J Eur Acad Dermatol Venereol; 2020 Oct; 34(10):e581-e582. PubMed ID: 32526085
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Testing recommendation for COVID-19 (SARS-CoV-2) in patients planned for surgery - continuing the service and 'suppressing' the pandemic.
    O' Connell K; Fitzpatrick F; Richmond A; Foley M; Martin F
    Br J Oral Maxillofac Surg; 2020 Jul; 58(6):733. PubMed ID: 32425293
    [No Abstract]   [Full Text] [Related]  

  • 13. The index case of SARS-CoV-2 in Scotland.
    Hill KJ; Russell CD; Clifford S; Templeton K; Mackintosh CL; Koch O; Sutherland RK
    J Infect; 2020 Jul; 81(1):147-178. PubMed ID: 32205138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital-at-Home as an Alternative to Release the Overload of Healthcare Systems During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic.
    Arias-de la Torre J; Alonso J; Martín V; Valderas JM
    J Am Med Dir Assoc; 2020 Jul; 21(7):990-991. PubMed ID: 32499181
    [No Abstract]   [Full Text] [Related]  

  • 15. Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2.
    Wen F; Yu H; Guo J; Li Y; Luo K; Huang S
    J Infect; 2020 Jun; 80(6):671-693. PubMed ID: 32145215
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation of different genes in the RT-PCR detection of SARS-CoV-2 in respiratory samples and its evolution in infection].
    Reina J; Suarez L
    Rev Esp Quimioter; 2020 Aug; 33(4):292-293. PubMed ID: 32459081
    [No Abstract]   [Full Text] [Related]  

  • 17. The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development.
    Dutta NK; Mazumdar K; Gordy JT
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32546606
    [No Abstract]   [Full Text] [Related]  

  • 18. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Transmission in Patients With Cancer Still Being Described.
    Tan J; Yang C
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):478. PubMed ID: 32402565
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to "Dose Rationale for Favipiravir Use in Patients Infected With SARS-CoV-2".
    Du YX; Chen XP
    Clin Pharmacol Ther; 2020 Aug; 108(2):190. PubMed ID: 32353191
    [No Abstract]   [Full Text] [Related]  

  • 20. Viral loads of SARS-CoV, MERS-CoV and SARS-CoV-2 in respiratory specimens: What have we learned?
    Al-Tawfiq JA
    Travel Med Infect Dis; 2020; 34():101629. PubMed ID: 32179122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.